OKYO Pharma Ltd

OKYO

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001849296

SEC filings (opens in a new tab)

Insider trades, last 90 days

7 buys · 0 sells

Bought $136.01K
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

19

+7 vs. Q1 2026
Total value $9.74M

View 13F holders

Superinvestors holding OKYO

0

None of the superinvestors held OKYO at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by OKYO insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Aug 7, 20264:15 PM ETAmended	Jul 21, 2026	BRANCACCIO JOHN PDirector	PPurchaseCOMMON STOCK	+5K	$1.477	+$7.39K	35.2K	+16.6%	SEC
Aug 7, 20264:15 PM ETAmended	Jul 22, 2026	Dempsey Robert JohnCHIEF EXECUTIVE OFFICER	PPurchaseCOMMON STOCK	+15K	$1.539	+$23.09K	15K	New position	SEC
Aug 7, 20264:15 PM ETAmended	Jul 21, 2026	JACOB GARY SCHIEF DEVELOPMENT OFFICER	PPurchaseCOMMON STOCK	+3.5K	$1.40	+$4.9K	112.42K	+3.2%	SEC
Aug 7, 20264:15 PM ETAmended	Jul 21, 2026	CERRONE GABRIELE MDirector, 10% Owner	PPurchaseCOMMON STOCK	+22.5K	$1.45	+$32.63K	10.87M	+0.2%	SEC
Aug 7, 20264:15 PM ETAmended	Jul 20, 2026	CERRONE GABRIELE MDirector, 10% Owner	PPurchaseCOMMON STOCK	+25K	$1.40	+$35K	10.85M	+0.2%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in OKYO at the end of Q2 2026.

Institutions holding OKYO in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Woodline Partners LP	3,652,768	$5.48M	0.02%	+5780.0%	Added
Stonepine Capital Management, LLC	862,996	$1.29M	0.99%	+12,996+1.5%	Added
Maven Securities LTD	809,317	$1.21M	0.08%	−366,218−31.2%	Reduced
Balyasny Asset Management LLC	580,596	$870.89K	0.00%	−4,200−0.7%	Reduced
Opaleye Management Inc.	375,204	$562.81K	0.05%	+375,204	New